Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correlation of dapagliflozin with vitamin D and K2 in type 2 diabetes mellitus
ChiCTR2100046532Phase 4Recruiting
- Sponsor
- Weishan People's Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Weishan People's Hospital. Primary endpoints: Serum vitamin D level and Serum vitamin K2 level. Started Jan 2022; status: recruiting.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2100046532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046532.